Navigation Links
Vanda Announces Submission To FDA Of A New Drug Application For Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
Date:5/31/2013

WASHINGTON, May 31, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VANDA) (NASDAQ: VNDA) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tasimelteon, a circadian regulator. Vanda is seeking FDA approval of tasimelteon for the treatment of Non-24-Hour Disorder (Non-24) in the totally blind. Tasimelteon was developed to address a significant unmet medical need, the treatment of Non-24, for which there are currently no FDA approved products.

Non-24 is a serious and rare, circadian rhythm disorder that affects the majority of totally blind individuals who lack light perception and who therefore cannot entrain (synchronize) their master body clock to the 24-hour day.  

"The NDA submission of tasimelteon for Non-24 represents a significant accomplishment for Vanda in our efforts to address unmet medical needs," said Mihael H. Polymeropoulos M.D ., Vanda's President and Chief Executive Officer.  "We are excited to have submitted an application for the first circadian regulator, representing a new class of therapeutics.  The data demonstrates that tasimelteon is able to reset the master body clock and synchronize the melatonin and cortisol circadian rhythms, resulting in significant clinical benefits to patients".   

Vanda previously announced that the FDA confirmed, at a recent pre-NDA meeting, that the efficacy, safety and supporting data package proposed to be included in the NDA would be adequate to support filing of the NDA for review by the Agency.  The tasimelteon Non-24 NDA includes data from the largest clinical program conducted to date for any investigational therapy for the treatment of Non-24.   

About Non-24-Hour Disorder
Non-24 is a serious, rare, and chr
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vanda to Present Tasimelteon Non-24 Phase III Data at Two Medical Meetings
2. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
3. Vanda Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 9, 2013
4. Vanda Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
5. Vanda Reports Successful Completion Of Pre-NDA Meeting With FDA On Tasimelteon For The Treatment Of Non-24-Hour Disorder In The Totally Blind
6. Vanda Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference
7. Vanda Pharmaceuticals Reports Fourth Quarter 2012 and Full Year 2012 Results
8. Vanda Announces Phase IIb/III Clinical Study In Major Depressive Disorder Did Not Meet The Primary Endpoint
9. Vanda Announces Positive Results in the Second Phase III Study (RESET) of Tasimelteon for the Treatment of Non-24-Hour Disorder
10. Vanda Pharmaceuticals to Announce Fourth Quarter 2012 Financial Results on February 12, 2013
11. Vanda Pharmaceuticals Reports Third Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Scott Steiger lives in St. ... an engineer for the past 20 years, he,s traveled extensively and ... He,s been to six of the seven continents. Travel is a ... http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 So ... pretty good idea of what,s required. His latest creation ...
(Date:11/26/2014)... -- A hernia is condition in which a ... wall of a weak muscle area. Obesity, poor nutrition, smoking, ... the causes of hernias. There are several types of hernia ... hernia is when part of the abdominal tissue/organ protrudes into ... area of the umbilicus. A hiatal hernia is when a ...
(Date:11/26/2014)...  CARsgen, a leader in the development of Chimeric ... variety of cancers, today announced the completion of a ... China -based healthcare private equity fund.   ... development of new therapeutics for liver, lung, stomach and ... Shanghai Renji Hospital, the company plans to initiate clinical ...
Breaking Medicine Technology:Steiger Has Created the First Pill Case Specifically Designed For Travel 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4CARsgen Completes Series A Financing 2
(Date:11/28/2014)... UWDress.com sells cheap tall cocktail ... greatly discounted dresses. Today, there is a new collection ... these dresses are offered at very low prices. It ... in the promotion launched by UWDress.com , UWDress.com is ... world, so the company has the power to ensure ...
(Date:11/28/2014)... November 28, 2014 The month of December ... 20,000 car accidents occurring in Florida every year in December ... importance of auto insurance policies. , "Optional auto insurance coverage ... insurance is not cheap I know, actually Florida is among ... are even higher, but what I see is that the ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Pathways ... December 2, 2014. This national movement was created to ... by giving to local charities and causes. This ... coincides with the kickoff of the holiday shopping season. ... to shopping and Cyber Monday is to online commerce. ...
(Date:11/28/2014)... Dr. Diane Walder, one of the South ... Dr. Bridgit Nolan to her practice as a cosmetic ... her dermatology residency at the University of Miami Miller ... Nolan to join her practice because of her ... only does Dr. Nolan strive to provide the utmost ...
(Date:11/28/2014)... 2014 Dr. Diane Walder, one of ... treatment to her practice called Ultrashape that is designed to ... inches in just six weeks. Ultrashape has been praised by ... in results when compared to other types of external fat ... it,” said Dr. Walder. , According to Dr. Walder, ...
Breaking Medicine News(10 mins):Health News:Graceful Tall Cocktail Dresses With New Features Just Added To UWDress.com 2Health News:Car Accident Attorney Sean M. Cleary on Auto Insurance Policies Essential for Florida Drivers 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 3
... Tampa, FL (Feb. 10, 2011) -- Preladenant, a non-dopaminergic ... receiving standard dopamine therapy, an international study led by ... of the double-blind, randomized clinical trial are reported online ... findings suggest that preladenant may offer a new supplemental ...
... More than two thousand physicians, some of ... in maternal-fetal medicine, especially high risk pregnancies, gathered ... to begin four days of intensive research presentations. ... Maternal-Fetal Medicine,s (SMFM) annual meeting, The Pregnancy Meeting ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... implanted device monitors fluid build-up in the lungs of heart ... As a result, the device reduces hospitalizations and improves quality ... the build-up of fluid pressure in the lungs that causes ...
... Ga. Regular exercise improves the ability of ... do math, Georgia Health Sciences University researchers report. ... 11-year-olds all sedentary when the study started - ... regular, vigorous physical activity is a part of every ...
... more than twice as likely to develop ulcers than people ... study from researchers at the University of Toronto. ... were abused during childhood and those were diagnosed with peptic ... Professor and Sandra Rotman Chair at U of T,s Factor-Inwentash ...
... EPA phased out the widespread residential use of chlorpyrifos ... risks to child neurodevelopment, these compounds were largely replaced ... replacement insecticides remained unclear, as they had never been ... the first study to examine the effects of these ...
Cached Medicine News:Health News:Non-dopaminergic drug preladenant reduces motor fluctuations in patients with Parkinson's disease 2Health News:SMFM highlights significance of spina bifida research findings 2Health News:Wireless Device Can Cut Heart Failure-Related Hospitalizations 2Health News:Wireless Device Can Cut Heart Failure-Related Hospitalizations 3Health News:Exercise helps overweight children think better, do better in math 2Health News:Common insecticide used in homes associated with delayed mental development of young children 2Health News:Common insecticide used in homes associated with delayed mental development of young children 3
... Package is a solid solution ... The package includes the Vibratome ... mounting blocks, v-block adapter, specimen ... rotating stage assembly for ease ...
... System provides a versatile means of sectioning ... The 1500 employs a vibrating blade ... embedding. The creation of artifacts, the ... activities, and other deleterious effect inherent in ...
... Vibratome 3000 Deluxe Sectioning System provides a ... animal, or plant tissues. The 3000 ... sectioning without freezing or embedding. The ... the destruction of enzyme activities, and other ...
The V-Block adapter is designed to allow round posts to be placed in the Vibratome vice....
Medicine Products: